top of page

MIAPaCa-2 Xenograft Model

Rincon Bio offers efficacy studies using the MIAPaCa-2 Xenograft Model at our U.S.-based facilities, with direct access to the scientists conducting your study.

Model Type:
Xenograft
Organ:
Pancreatic
Derivation:
Primary pancreatic ductal carcinoma of a 65yo male
Mutations:
KRAS, TP53
NCI60:
No
Weeks from stratification to termination (average):
8

MIAPaCa-2 Growth Curve

(Representative of studies performed at Rincon Bio)

Representative tumor growth curve for the MIAPaCa-2 xenograft model from studies performed at Rincon Bio.

For more information on this model, including available control data, please Contact Us, or request a Quote below

All Xenograft Models

All Syngeneic Models

bottom of page